In shallow knowledge, all I knew was that breast cancer in men is rare but deadly, as there are limited treatment options and clinical trials for an early diagnosis. But as I continued to do research about male breast cancer, I discovered that it was a lot less common than I had assumed, and the treatments provided were not specific to males, but were derived from females, which was then assumed to work on males. I was most surprised to find that there are no clinical trials done on men about breast cancer, which I think is perplexing given that the issue has already been presented at hand. With that said, I think as I continued to know more about male breast cancer, the more my writing flourishes to smooth the surface and pave the way for a clear understanding of male breast cancer. I discovered that I have quite the talent for metaphorically describing topics whilst still staying on topic. I also discovered that I barely make grammatical errors. 

If I were stuck in an elevator and had to give a short two-minute talk to someone about male breast cancer research, I would say that male breast cancer is a rare condition presented in men, about 1% prevalence. Though rare, when presented becomes a death sentence due to the delay in diagnosis and limited resources provided, as breast cancer, for a long time, was categorized as exclusively a female condition. I learned that all genders should be required to go through a mammography exam every now and then to assess breast tissue for any potential tumor growth. Furthermore, genetically, men can be carriers of the male breast cancer receptor; it would be best to get an examination early on, even without the symptoms, to prevent progression or worsening of tumor cells.